Biocytogen
Kae Hood, with a Bachelor of Arts in Economics from Hosei University and an Executive MBA from Fox School of Business at Temple University, has extensive experience in financial and operational management. In the past years, Kae has held various key roles such as Financial Controller at Biocytogen, Controller at Otuska Chemical America, and Operation Management at Kaei Shouji Inc. Currently serving as the Financial Controller at Biocytogen, Kae is a seasoned professional in the field with a strong background in finance and accounting.
This person is not in any offices
Biocytogen
2 followers
Biocytogen is a preclinical stage biotech that provides a one-stop solution for antibody discovery from target to IND application. With cutting-edge technologies, state-of-art animal facility, and world-class platforms for antibody drug discovery, Biocytogen offers animal model generation, antibody fully human-mouse (RenMab mouse), therapeutic antibody discovery and development, in vivo/in vitro preclinical studies, CMC/CDMO, and regulatory affairs support.